Skip to main content

Resource Library

16 July 2024

The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?

Blog
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma
ANALYST PAPER - CHINA AND RUSSIA COOPERATION

How are China and Russia advancing their shared agendas?

Download our recent analyst paper to understand the key implications of recent China-Russia diplomatic developments.

Download Guide

Resource Library

Visit our Resources hub

18 December 2024

China Is Expanding Its Footprint in Latin America and the Caribbean

Blog
The recent China-Peru joint inauguration of the Chancay Port is the latest example of the People’s Republic of China (PRC)’s growing influence in Latin America and the Caribbean (LAC).
16 December 2024

Hong Kong’s Eroding Autonomy Adds Risks to Its Business Environment

Blog
In November, 45 Hong Kong politicians, activists, union officials, academics, and student leaders were sentenced to up to 10 years in prison on the charge of subversion under the national security laws of the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region (HKSAR).
12 December 2024

PRC Initiates Unreliable Entity List Investigation Against PVH Group

Blog
On September 24, 2024, the Ministry of Commerce (MOFCOM) of the People’s Republic of China (PRC) announced that it was initiating an investigation into the practices of the U.S. PVH Group in accordance with Article 2 of the PRC’s “Provisions on Unreliable Entity List [UEL]” (不可靠实体清单规定, UEL Provisions).
Make contact with Pamir

Ready to get started on your
China strategy?

Get in touch with us

Contact Pamir